HealthStream Gelecekteki Büyüme
Future kriter kontrolleri 1/6
HealthStream is forecast to grow earnings and revenue by 5.8% and 6% per annum respectively while EPS is expected to grow by 3.1% per annum.
Anahtar bilgiler
5.8%
Kazanç büyüme oranı
3.1%
EPS büyüme oranı
Healthcare Services kazanç büyümesi | 30.6% |
Gelir büyüme oranı | 6.0% |
Gelecekteki özkaynak getirisi | n/a |
Analist kapsamı | Good |
Son güncelleme | 23 Oct 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
HealthStream, Inc.'s (NASDAQ:HSTM) Shareholders Might Be Looking For Exit
Aug 08We Ran A Stock Scan For Earnings Growth And HealthStream (NASDAQ:HSTM) Passed With Ease
Jul 17HealthStream, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Apr 24HealthStream GAAP EPS of $0.10 beats by $0.05, revenue of $65.64M misses by $0.63M
Jul 25HealthStream's (NASDAQ:HSTM) Returns Have Hit A Wall
Jun 24A Look At The Fair Value Of HealthStream, Inc. (NASDAQ:HSTM)
Jun 04We Discuss Why HealthStream, Inc.'s (NASDAQ:HSTM) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
May 14HealthStream up after-hours after earnings beat; raises FY 2021 guidance
Apr 26Returns At HealthStream (NASDAQ:HSTM) Appear To Be Weighed Down
Apr 08Has HealthStream, Inc. (NASDAQ:HSTM) Stock's Recent Performance Got Anything to Do With Its Financial Health?
Mar 21Have HealthStream, Inc. (NASDAQ:HSTM) Insiders Been Selling Their Stock?
Mar 03Analysts Are Updating Their HealthStream, Inc. (NASDAQ:HSTM) Estimates After Its Full-Year Results
Feb 24Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
12/31/2026 | 326 | 23 | 34 | N/A | 2 |
12/31/2025 | 306 | 20 | 28 | 59 | 6 |
12/31/2024 | 291 | 19 | 27 | 57 | 6 |
9/30/2024 | 288 | 20 | 32 | 60 | N/A |
6/30/2024 | 285 | 18 | 38 | 66 | N/A |
3/31/2024 | 283 | 18 | 37 | 64 | N/A |
12/31/2023 | 279 | 15 | 36 | 64 | N/A |
9/30/2023 | 277 | 13 | 31 | 58 | N/A |
6/30/2023 | 274 | 13 | 22 | 49 | N/A |
3/31/2023 | 270 | 12 | 24 | 51 | N/A |
12/31/2022 | 267 | 12 | 26 | 51 | N/A |
9/30/2022 | 263 | 9 | 24 | 49 | N/A |
6/30/2022 | 259 | 7 | 20 | 46 | N/A |
3/31/2022 | 259 | 6 | 19 | 44 | N/A |
12/31/2021 | 257 | 6 | 17 | 42 | N/A |
9/30/2021 | 254 | 7 | 18 | 42 | N/A |
6/30/2021 | 251 | 8 | 24 | 47 | N/A |
3/31/2021 | 247 | 9 | 28 | 49 | N/A |
12/31/2020 | 245 | 14 | 17 | 36 | N/A |
9/30/2020 | 246 | 17 | 26 | 44 | N/A |
6/30/2020 | 247 | 18 | 25 | 43 | N/A |
3/31/2020 | 250 | 17 | 30 | 56 | N/A |
12/31/2019 | 254 | 14 | 29 | 66 | N/A |
9/30/2019 | 251 | 14 | 28 | 67 | N/A |
6/30/2019 | 249 | 13 | 27 | 65 | N/A |
3/31/2019 | 242 | 14 | 20 | 51 | N/A |
12/31/2018 | 232 | 13 | 25 | 43 | N/A |
9/30/2018 | 227 | 13 | 25 | 40 | N/A |
6/30/2018 | 222 | 12 | N/A | 39 | N/A |
3/31/2018 | 218 | 11 | N/A | 39 | N/A |
12/31/2017 | 215 | 9 | N/A | 47 | N/A |
9/30/2017 | 218 | 5 | N/A | 45 | N/A |
6/30/2017 | 222 | 5 | N/A | 47 | N/A |
3/31/2017 | 224 | 4 | N/A | 35 | N/A |
12/31/2016 | 192 | 5 | N/A | 24 | N/A |
9/30/2016 | 223 | 6 | N/A | 24 | N/A |
6/30/2016 | 219 | 7 | N/A | 16 | N/A |
3/31/2016 | 216 | 7 | N/A | 32 | N/A |
12/31/2015 | 209 | 9 | N/A | 35 | N/A |
9/30/2015 | 198 | 9 | N/A | 31 | N/A |
6/30/2015 | 189 | 10 | N/A | 31 | N/A |
3/31/2015 | 179 | 11 | N/A | 34 | N/A |
12/31/2014 | 171 | 10 | N/A | 34 | N/A |
9/30/2014 | 162 | 10 | N/A | 33 | N/A |
6/30/2014 | 152 | 8 | N/A | 38 | N/A |
3/31/2014 | 141 | 8 | N/A | 32 | N/A |
12/31/2013 | 132 | 8 | N/A | 27 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: HSTM's forecast earnings growth (5.8% per year) is above the savings rate (2.5%).
Kazançlar ve Piyasa: HSTM's earnings (5.8% per year) are forecast to grow slower than the US market (15.4% per year).
Yüksek Büyüme Kazançları: HSTM's earnings are forecast to grow, but not significantly.
Gelir ve Pazar: HSTM's revenue (6% per year) is forecast to grow slower than the US market (8.9% per year).
Yüksek Büyüme Geliri: HSTM's revenue (6% per year) is forecast to grow slower than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if HSTM's Return on Equity is forecast to be high in 3 years time